Acidifying enemas (lactitol and lactose) vs. nonacidifying enemas (tap water) to treat acute portal‐systemic encephalopathy: A double‐blind, randomized clinical trial
Misael Uribe, Octavio Campollo, Florencia Vargas, Gian Paolo Ravelli, Fernando Mundo, Laura Zapata, Sofia Gil, Guillermo Garcia‐Ramos – 1 July 1987 – A double‐blind, controlled trial to study the efficacy of acidifying enemas of lactitol, a new galactoside‐sorbitol disaccharide, and lactose vs. nonacidifying tapwater enemas was performed in 45 episodes of acute portal‐systemic encephalopathy. At the time of randomization, all patients had encephalopathy of at least Grade 2+ severity, delay in the performance of number connection tests and hyperammonemia.